Product Images Tizanidine Hydrochloride

The text describes the improvement in Ashworth score for a drug called Tizanidine at different points in a study (End of Titration, End of Maintenance, and Endpoint) with a mean dose of 26.8 mg.*

This is a description of Tizanidine Hydrochloride capsules, a medication that is not interchangeable with tizanidine tablets or Zanaflex tablets. Each hard gelatin capsule contains 2.29mg of tizanidine hydrochloride, equivalent to 2mg of tizanidine base. The usual dosage is included in the package insert. The capsules should be stored at 20° to 25°C (58° to 77°F) and dispensed in containers with child-resistant closures. This medication is manufactured by Cadia Healthcare Ltd in Ahmedabad, India. Zanaflex is a registered trademark of Acorda Therapeutics Inc.*

Tizanidine Hydrochloride Capsules are available in containers of 150 capsules and are used for medication to treat muscle spasms. They contain 4.58mg of tizanidine hydrochloride equivalent to 4mg of tizanidine base. These capsules are not interchangeable with tizanidine tablets or Zanaflex tablets. Dosage and other relevant information can be found in the package insert. They should be stored at room temperature and out of reach of children in containers with child-resistant closures. "Zanaflex" is a registered trademark of Acorda Therapeutics Inc. Cadila Healthcare Ltd., in India, produces the capsules.*

This is a medication called Tizanidine Hydrochloride available in capsule form. It should not be confused with other forms of Tizanidine medication. Each capsule contains 6.87 mg Tizanidine Hydrochloride. The dosage and prescribing information can be found in the package insert. It should be stored at controlled room temperature and kept out of reach of children. Zanaflex is a registered trademark of Acorda Therapeutics Inc. The medication is manufactured by Cadia Healthcare Ltd in India.*